Y-Intercept (Hong Kong) Ltd
•CIK: 1772875•Filing: Q4 2025
Y-Intercept (Hong Kong) Ltd, managed by the renowned quantitative strategist and former Renaissance Technologies analyst, Yves Hilpisch, maintains a concentrated portfolio with a focus on tech and biotech sectors, currently holding 1,482 positions. The fund has recently made notable moves by adding Robinhood (RBLX), Affirm (AZO), and Biogen (BIIB), while significantly increasing positions in Okta (ON) by 1,889% and Broadcom (AVGO) by 1,194%, reflecting a strategy of capitalizing on high-growth opportunities.
Total AUM
$4.5B
QoQ Performance
+7.3%
Positions
1,396
Top 10 Concentration
22.4%
Latest Filing
Q4 2025
Top Holdings Allocation
NVDA2.6%
AVGO2.5%
AAPL1.6%
MSFT1.1%
SCHW0.8%
RIVN0.6%
RBLX0.6%
NFLX0.6%
📈 Biggest Buys
📉 Biggest Sells
Sector Breakdown
Other67.8%
Technology16.3%
Financial5.7%
Consumer1.9%
Communication1.9%
Industrial1.8%
Energy1.8%
Healthcare1.0%
🚪 Exited Positionssold since Q3 2025
+1373 more exited positions
Changes from Q3 2025
NEW69 new positions
↑108 increased
↓23 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023